Safety, PK/PD, and anti-tumor activity of RO6874281, an engineered variant of interleukin-2 (IL-2v) targeted to tumor-associated fibroblasts via binding to fibroblast …
…, J Martin-Liberal, UN Lassen, I Melero Bermejo… - 2018 - ascopubs.org
e15155 Background: High-dose (HD) IL-2 is approved for patients with melanoma and renal
cell carcinoma but is associated with significant toxicity, given only in an inpatient setting. …
cell carcinoma but is associated with significant toxicity, given only in an inpatient setting. …
Selection of extreme phenotypes: the role of clinical observation in translational research
…, J García-Foncillas, I Melero Bermejo - Clinical and …, 2010 - Springer
Systematic collection of phenotypes and their correlation with molecular data has been
proposed as a useful method to advance in the study of disease. Although some databases for …
proposed as a useful method to advance in the study of disease. Although some databases for …
Phase II study SECOMBIT (sequential combo immuno and target therapy study): A subgroup analysis with a longer follow-up.
…, MT Fierro, C Lebbe, H Helgadottir, I Melero Bermejo… - 2022 - ascopubs.org
9535 Background: To investigate the best sequential strategy, we started the SECOMBIT
study, a randomized three parallel arms phase 2 study (NCT02631447). We used the …
study, a randomized three parallel arms phase 2 study (NCT02631447). We used the …
[HTML][HTML] Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs
…, F Issa, CE de Andrea, I Melero Bermejo… - Nature …, 2023 - nature.com
Single cell spatial interrogation of the immune-structural interactions in COVID −19 lungs is
challenging, mainly because of the marked cellular infiltrate and architecturally distorted …
challenging, mainly because of the marked cellular infiltrate and architecturally distorted …
Serum interleukin 8 (IL-8) may serve as a biomarker of response to immuno-oncology (IO) therapy.
3025 Background: Biomarkers are needed to identify pts responsive to IO therapies. IL-8 is
a proinflammatory chemokine that promotes tumor immune escape. High serum IL-8 levels …
a proinflammatory chemokine that promotes tumor immune escape. High serum IL-8 levels …
Whole exome sequencing of germline DNA of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung adenocarcinoma …
…, J Zulueta, R Pio Oses, I Melero Bermejo… - 2019 - ascopubs.org
1540 Background: Individual susceptibility to carcinogens may depend on the genetic
background. We characterized the constitutional exome of individuals presenting extreme …
background. We characterized the constitutional exome of individuals presenting extreme …
Unbiased single cell spatial analysis localises inflammatory clusters of immature neutrophils-CD8 T cells to alveolar progenitor cells in fatal COVID-19 lungs
…, A Cross, F Issa, CE de Andrea, IM Bermejo… - MedRxiv, 2022 - medrxiv.org
Single cell spatial interrogation of the immune-structural interactions in COVID -19 lungs is
challenging, mainly because of the marked cellular infiltrate and architecturally distorted …
challenging, mainly because of the marked cellular infiltrate and architecturally distorted …
Phase 1b/2 study of nivolumab in combination with an anti–IL-8 monoclonal antibody, BMS-986253, in a biomarker-enriched population of patients with advanced …
I Melero Bermejo, EM Jaffee, D Davar, J Cardarelli… - 2018 - ascopubs.org
TPS3109 Background: Interleukin 8 (IL-8) is a chemokine that has been suggested to play a
predominant role in tumor immune escape by promoting an immunosuppressive tumor …
predominant role in tumor immune escape by promoting an immunosuppressive tumor …
Nuevos tratamientos para el carcinoma renal
…, CA Alegría, JGF López, IM Bermejo… - Anales del sistema …, 2007 - dialnet.unirioja.es
El cáncer renal presenta varias características que lo diferencian de otros tumores. El
aumento de supervivencia observado en pacientes con carcinoma renal metastásico tras la …
aumento de supervivencia observado en pacientes con carcinoma renal metastásico tras la …
El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones viráles crónicas
…, JMP Valtueña, IM Bermejo - Anales del sistema …, 2006 - dialnet.unirioja.es
La manipulación farmacológica del sistema inmunitario para conseguir respuestas
linfocitarias de mayor intensidad tiene aplicación potencial en inmunoterapia tumoral y en el …
linfocitarias de mayor intensidad tiene aplicación potencial en inmunoterapia tumoral y en el …